Apixaban Cuts Stroke but Ups Bleeding in Subclinical AF


Further analyses from the ARTESIA study and the previous NOAH-AFNET 6 trial are needed to try to identify groups where the benefit may outweigh the risk, researchers say.
Medscape Medical News

Articles You May Like

Sanctuary Chicago: Arrests of Venezuelan Illegals Rise 11,000% Since 2021
San Francisco Business Owner Blames City for Letting Crime Ruin Area
Apple Watch Series 9 vs. Ultra 2: don’t make a mistake | Digital Trends
NATO front-runner Mark Rutte faces flak over low Dutch defense spending
Last Train Home brought me back to my Oregon Trail days | Digital Trends